IRIDEX (IRIX) director buys 28,157 and 21,843 common shares
IRIDEX Corporation (IRIX) director share purchases disclosed.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
IRIDEX Corporation (IRIX) director share purchases disclosed. A company director reported open-market purchases of common stock in two transactions. On 11/14/2025, the director bought 28,157 shares at a weighted average price of $0.9676 per share, in multiple trades between $0.9367 and $0.98. On 11/17/2025, the director bought 21,843 shares at a weighted average price of $0.9654 per share, in multiple trades between $0.95 and $0.98.
After these transactions, the director beneficially owns 250,674 shares directly. In addition, 69,300 shares are held indirectly by the director’s spouse, and 30,026 shares are held indirectly through trusts identified in the footnotes. The filing notes that detailed trade‑by‑trade pricing information is available upon request.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 21,843 | $0.9654 | $21K |
| Purchase | Common Stock | 28,157 | $0.9676 | $27K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9367 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- F2. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.95 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- F3. The shares are held by William M. Moore Trust, William M. Moore, Trustee Under Agreement Dated 08/16/2016 & Patricia A. Moore Trust, Patricia A. Moore, Trustee Under Agreement Dated 08/17/2016 Tenants in Common.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IRIDEX (IRIX) report in this Form 4?
The filing reports that a director of IRIDEX purchased common stock in the open market in two separate transactions on 11/14/2025 and 11/17/2025.
Were the IRIDEX (IRIX) director’s purchases made in multiple trades?
Yes. Each weighted average price reflects multiple transactions: 11/14/2025 trades ranged from $0.9367 to $0.98, and 11/17/2025 trades ranged from $0.95 to $0.98.
Does this IRIDEX (IRIX) Form 4 include any derivative securities?
No derivative securities are reported in the excerpted Table II; only common stock acquisitions are shown in Table I.
Who signed the IRIDEX (IRIX) Form 4 for the reporting person?
The Form 4 was signed by /s/ Nilo De Castro as attorney-in-fact for the reporting person, William M. Moore.
AI-generated analysis. How Rhea-AI works. Not financial advice.